[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Frontline AIDS\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":40},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":15,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":4},"100562516",false,"NCT06604182","Innovate, Involve, Inspire","Community-based HCV Testing and Treatment of People Who Inject Drugs: Innovate, Involve, Inspire","Inclusion Criteria:\n\n* Drug use in the past 90 days\n* Age 18 and above\n* Positive for HCV RNA\n\nExclusion Criteria:\n\n* No meeting inclusion criteria\n* Pregnancy",true,"ALL","18 Years","60 Years",{"count":20,"type":21},1454,"ESTIMATED","INTERVENTIONAL",[24],"NA","The study will test a Community-based Simplified HCV Testing and Treatment Algorithm (CBSA), implemented at community harm reduction fixed or mobile sites.\n\nAll potential participants with positive anti-HCV test will undergo diagnostic procedures including HCV-RNA testing. Those eligible for CBSA will be prescribed a fixed dose combination tablet: sofosbuvir\u002Fdaclatasvir.\n\nSustained virologic response (SVR) will be assessed 12 weeks after treatment completion. All those who achieve SVR will be tested for HCV\\_RNA at six and 12 months after SVR12.",[27],"HCV","NOT_YET_RECRUITING","2024-09-17",{"date":31,"type":32},"2024-09-19","ACTUAL",{"date":34,"type":21},"2025-01",{"date":36,"type":21},"2026-07",{"name":38,"class":39},"Frontline AIDS","OTHER",""]